These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 9576228)

  • 41. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation.
    Reinhartz O; Farrar DJ; Hershon JH; Avery GJ; Haeusslein EA; Hill JD
    J Thorac Cardiovasc Surg; 1998 Oct; 116(4):633-40. PubMed ID: 9766593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duration of left ventricular assist device support affects transplant survival.
    Ashton RC; Goldstein DJ; Rose EA; Weinberg AD; Levin HR; Oz MC
    J Heart Lung Transplant; 1996 Nov; 15(11):1151-7. PubMed ID: 8956124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recovery of major organ function in patients awaiting heart transplantation with Thoratec ventricular assist devices. Thoratec Ventricular Assist Device Principal Investigators.
    Farrar DJ; Hill JD
    J Heart Lung Transplant; 1994; 13(6):1125-32. PubMed ID: 7865520
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients.
    Ochiai Y; McCarthy PM; Smedira NG; Banbury MK; Navia JL; Feng J; Hsu AP; Yeager ML; Buda T; Hoercher KJ; Howard MW; Takagaki M; Doi K; Fukamachi K
    Circulation; 2002 Sep; 106(12 Suppl 1):I198-202. PubMed ID: 12354733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.
    Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W
    Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pneumatic pulsatile ventricular assist device as a bridge to heart transplantation in pediatric patients.
    Amodeo A; Brancaccio G; Michielon G; Filippelli S; Ricci Z; Morelli S; Gagliardi MG; Iacobelli R; Pongiglione G; Di Donato RM
    Artif Organs; 2010 Nov; 34(11):1017-22. PubMed ID: 21092045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preoperative risk factors for mortality after biventricular assist device implantation.
    Zahr F; Ootaki Y; Starling RC; Smedira NG; Yamani M; Thuita L; Fukamachi K
    J Card Fail; 2008 Dec; 14(10):844-9. PubMed ID: 19041048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
    Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of a pulsatile right ventricular assist device and continuous arteriovenous hemodialysis in a 57-year-old man with a pulsatile left ventricular assist device.
    Chen JM; Levin HR; Catanese KA; Sistino JJ; Landry DW; Rose EA; Oz MC
    J Heart Lung Transplant; 1995; 14(1 Pt 1):186-91. PubMed ID: 7727468
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence and clinical management of life-threatening left ventricular assist device failure.
    Birks EJ; Tansley PD; Yacoub MH; Bowles CT; Hipkin M; Hardy J; Banner NR; Khaghani A
    J Heart Lung Transplant; 2004 Aug; 23(8):964-9. PubMed ID: 15312826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
    Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term mechanical support with the HeartMate II LVAS.
    Loforte A; Montalto A; Ranocchi F; Casali G; Luzi G; Della Monica PL; Sbaraglia F; Polizzi V; Distefano G; Musumeci F
    Transplant Proc; 2009 May; 41(4):1357-9. PubMed ID: 19460559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation.
    Taghavi S; Zuckermann A; Ankersmit J; Wieselthaler G; Rajek A; Laufer G; Wolner E; Grimm M
    Ann Thorac Surg; 2004 Nov; 78(5):1644-9. PubMed ID: 15511449
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of failure of the right side of the heart and increased pulmonary resistance on mechanical circulatory support with use of the miniaturized HIA-VAD displacement pump system.
    Waldenberger F; Kim YI; Laycock S; Meyns B; Flameng W
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):484-93. PubMed ID: 8751517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heartmate II axial-flow left ventricular assist system: management, clinical review and personal experience.
    Loforte A; Montalto A; Ranocchi F; Casali G; Luzi G; Monica PL; Sbaraglia F; Polizzi V; Distefano G; Musumeci F
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):765-71. PubMed ID: 19465866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system.
    Vetter HO; Kaulbach HG; Schmitz C; Forst A; Uberfuhr P; Kreuzer E; Pfeiffer M; Brenner P; Dewald O; Reichart B
    J Thorac Cardiovasc Surg; 1995 Jan; 109(1):74-80. PubMed ID: 7815810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.